Roche News
Most Popular Roche Story
Sanofi, Novartis favor diagnostics partnerships over M&A
The initial speculation--or was it a wish?--that a Sanofi ($SNY) or Novartis ($NVS) might mount a counterbid to Roche's hostile $5.7 billion offer for Illumina was chilled rather effectively by a Read more...
Latest Headlines
- February 10, 2012
- February 1, 2012
- January 30, 2012
- January 27, 2012
- January 26, 2012
- January 25, 2012
- January 23, 2012
- January 19, 2012
- January 18, 2012
- January 11, 2012
- January 11, 2012
- January 3, 2012
- December 23, 2011
- December 22, 2011
- December 19, 2011
- December 16, 2011
- December 14, 2011
- December 7, 2011
- December 1, 2011
- November 29, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
